Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis.

Journal of arrhythmia

Bazoukis G, Letsas KP, Korantzopoulos P, Thomopoulos C, Vlachos K, Georgopoulos S, Karamichalakis N, Saplaouras A, Efremidis M, Sideris A.
PMID: 29021843
J Arrhythm. 2017 Oct;33(5):417-423. doi: 10.1016/j.joa.2017.04.005. Epub 2017 May 01.

BACKGROUND: Cardiac resynchronization therapy (CRT) improves both morbidity and mortality in selected patients with heart failure and increased QRS duration. However, chronic kidney disease (CKD) may have an adverse effect on patient outcome. The aim of this systematic review...

Cite
Bazoukis G, Letsas KP, Korantzopoulos P, et al. Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis. J Arrhythm. 2017;33(5):417-423doi: 10.1016/j.joa.2017.04.005.
Bazoukis, G., Letsas, K. P., Korantzopoulos, P., Thomopoulos, C., Vlachos, K., Georgopoulos, S., Karamichalakis, N., Saplaouras, A., Efremidis, M., & Sideris, A. (2017). Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis. Journal of arrhythmia, 33(5), 417-423. https://doi.org/10.1016/j.joa.2017.04.005
Bazoukis, G, et al. "Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis." Journal of arrhythmia vol. 33,5 (2017): 417-423. doi: https://doi.org/10.1016/j.joa.2017.04.005
Bazoukis G, Letsas KP, Korantzopoulos P, Thomopoulos C, Vlachos K, Georgopoulos S, Karamichalakis N, Saplaouras A, Efremidis M, Sideris A. Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis. J Arrhythm. 2017 Oct;33(5):417-423. doi: 10.1016/j.joa.2017.04.005. Epub 2017 May 01. PMID: 29021843; PMCID: PMC5634685.
Copy Download .nbib Format: NLM
Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation.

Cases journal

Korantzopoulos P, Grekas G, Pappas T, Goudevenos JA.
PMID: 18789158
Cases J. 2008 Sep 12;1(1):152. doi: 10.1186/1757-1626-1-152.

In this report we briefly describe a patient with a dual chamber implantable cardioverter defibrillator in the context of severe ischemic cardiomyopathy who developed persistent atrial fibrillation. After appropriate anticoagulation and under mild sedation the patient was successfully cardioverted...

Cite
Korantzopoulos P, Grekas G, Pappas T, et al. Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation. Cases J. 2008;1(1):152doi: 10.1186/1757-1626-1-152.
Korantzopoulos, P., Grekas, G., Pappas, T., & Goudevenos, J. A. (2008). Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation. Cases journal, 1(1), 152. https://doi.org/10.1186/1757-1626-1-152
Korantzopoulos, Panagiotis, et al. "Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation." Cases journal vol. 1,1 (2008): 152. doi: https://doi.org/10.1186/1757-1626-1-152
Korantzopoulos P, Grekas G, Pappas T, Goudevenos JA. Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation. Cases J. 2008 Sep 12;1(1):152. doi: 10.1186/1757-1626-1-152. PMID: 18789158; PMCID: PMC2553765.
Copy Download .nbib Format: NLM
High prevalence of subclinical peripheral artery disease in Greek hospitalized patients.

European journal of internal medicine

Antonopoulos S, Kokkoris S, Stasini F, Mylonopoulou M, Lepeniotis G, Mikros S, Korantzopoulos P, Giannoulis G.
PMID: 15967334
Eur J Intern Med. 2005 Jun;16(3):187-191. doi: 10.1016/j.ejim.2005.02.002.

BACKGROUND: Peripheral artery disease (PAD) represents a common manifestation of systemic atherosclerosis that is associated with an increased risk of cardiovascular death and ischemic events but one that may be underdiagnosed in clinical practice. The purpose of this study...

Cite
Antonopoulos S, Kokkoris S, Stasini F, et al. High prevalence of subclinical peripheral artery disease in Greek hospitalized patients. Eur J Intern Med. 2005;16(3):187-191doi: 10.1016/j.ejim.2005.02.002.
Antonopoulos, S., Kokkoris, S., Stasini, F., Mylonopoulou, M., Lepeniotis, G., Mikros, S., Korantzopoulos, P., & Giannoulis, G. (2005). High prevalence of subclinical peripheral artery disease in Greek hospitalized patients. European journal of internal medicine, 16(3), 187-191. https://doi.org/10.1016/j.ejim.2005.02.002
Antonopoulos, Stavros, et al. "High prevalence of subclinical peripheral artery disease in Greek hospitalized patients." European journal of internal medicine vol. 16,3 (2005): 187-191. doi: https://doi.org/10.1016/j.ejim.2005.02.002
Antonopoulos S, Kokkoris S, Stasini F, Mylonopoulou M, Lepeniotis G, Mikros S, Korantzopoulos P, Giannoulis G. High prevalence of subclinical peripheral artery disease in Greek hospitalized patients. Eur J Intern Med. 2005 Jun;16(3):187-191. doi: 10.1016/j.ejim.2005.02.002. PMID: 15967334.
Copy Download .nbib Format: NLM
Surgical management of cardiac implantable electronic device infections.

Journal of thoracic disease

Koutentakis M, Siminelakis S, Korantzopoulos P, Petrou A, Petrou A, Priavali H, Priavali E, Mpakas A, Gesouli H, Gesouli E, Apostolakis E, Apostolakis E, Tsakiridis K, Zarogoulidis P, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Tsiouda T, Zarogoulidis K.
PMID: 24672692
J Thorac Dis. 2014 Mar;6:S173-9. doi: 10.3978/j.issn.2072-1439.2013.10.23.

PURPOSE: The infection of cardiac implantable electronic devices (CIED) is a serious and potentially lethal complication. The population at risk is growing, as the device implantation is increasing especially in older patients with associated comorbid conditions. Our purpose was...

Cite
Koutentakis M, Siminelakis S, Korantzopoulos P, et al. Surgical management of cardiac implantable electronic device infections. J Thorac Dis. 2014;6:S173-9doi: 10.3978/j.issn.2072-1439.2013.10.23.
Koutentakis, M., Siminelakis, S., Korantzopoulos, P., Petrou, A., Petrou, A., Priavali, H., Priavali, E., Mpakas, A., Gesouli, H., Gesouli, E., Apostolakis, E., Apostolakis, E., Tsakiridis, K., Zarogoulidis, P., Katsikogiannis, N., Kougioumtzi, I., Machairiotis, N., Tsiouda, T., & Zarogoulidis, K. (2014). Surgical management of cardiac implantable electronic device infections. Journal of thoracic disease, 6S173-9. https://doi.org/10.3978/j.issn.2072-1439.2013.10.23
Koutentakis, Michael, et al. "Surgical management of cardiac implantable electronic device infections." Journal of thoracic disease vol. 6 (2014): S173-9. doi: https://doi.org/10.3978/j.issn.2072-1439.2013.10.23
Koutentakis M, Siminelakis S, Korantzopoulos P, Petrou A, Petrou A, Priavali H, Priavali E, Mpakas A, Gesouli H, Gesouli E, Apostolakis E, Apostolakis E, Tsakiridis K, Zarogoulidis P, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Tsiouda T, Zarogoulidis K. Surgical management of cardiac implantable electronic device infections. J Thorac Dis. 2014 Mar;6:S173-9. doi: 10.3978/j.issn.2072-1439.2013.10.23. PMID: 24672692; PMCID: PMC3966150.
Copy Download .nbib Format: NLM
Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Bazoukis G, Tse G, Naka KK, Kalfakakou V, Vlachos K, Saplaouras A, Letsas KP, Korantzopoulos P, Thomopoulos C, Michelongona P, Bazoukis X, González-Salvado V, Liu T, Michalis LK, Baranchuk A, Itoh T, Efremidis M, Tsioufis C, Stavrakis S.
PMID: 29807192
Hellenic J Cardiol. 2018 Sep - Oct;59(5):262-267. doi: 10.1016/j.hjc.2018.05.005. Epub 2018 May 25.

Natural disasters such as tsunami, hurricanes, and earthquakes may have a negative impact on cardiac health. The aim of our systematic review is to evaluate the impact of earthquakes on the incidence of acute coronary syndromes and cardiac mortality...

Cite
Bazoukis G, Tse G, Naka KK, et al. Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic J Cardiol. 2018;59(5):262-267doi: 10.1016/j.hjc.2018.05.005.
Bazoukis, G., Tse, G., Naka, K. K., Kalfakakou, V., Vlachos, K., Saplaouras, A., Letsas, K. P., Korantzopoulos, P., Thomopoulos, C., Michelongona, P., Bazoukis, X., González-Salvado, V., Liu, T., Michalis, L. K., Baranchuk, A., Itoh, T., Efremidis, M., Tsioufis, C., & Stavrakis, S. (2018). Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 59(5), 262-267. https://doi.org/10.1016/j.hjc.2018.05.005
Bazoukis, George, et al. "Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 59,5 (2018): 262-267. doi: https://doi.org/10.1016/j.hjc.2018.05.005
Bazoukis G, Tse G, Naka KK, Kalfakakou V, Vlachos K, Saplaouras A, Letsas KP, Korantzopoulos P, Thomopoulos C, Michelongona P, Bazoukis X, González-Salvado V, Liu T, Michalis LK, Baranchuk A, Itoh T, Efremidis M, Tsioufis C, Stavrakis S. Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic J Cardiol. 2018 Sep - Oct;59(5):262-267. doi: 10.1016/j.hjc.2018.05.005. Epub 2018 May 25. PMID: 29807192.
Copy Download .nbib Format: NLM
The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study.

Hippokratia

Bazoukis G, Saplaouras A, Letsas KP, Yeung C, Xydonas S, Karamichalakis N, Thomopoulos C, Manolatos D, Papathanakos G, Vlachos K, Tse G, Korantzopoulos P, Efremidis M, Sideris A, Naka KK.
PMID: 32581497
Hippokratia. 2019 Jul-Sep;23(3):118-125.

BACKGROUND: Cardiac resynchronization therapy (CRT) is an established therapeutic option for patients with heart failure (HF) and left ventricular ejection fraction (LVEF) ≤35 % who meet specific criteria according to current guidelines. However, up to 40 % of patients...

Cite
Bazoukis G, Saplaouras A, Letsas KP, et al. The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study. Hippokratia. 2019;23(3):118-125
Bazoukis, G., Saplaouras, A., Letsas, K. P., Yeung, C., Xydonas, S., Karamichalakis, N., Thomopoulos, C., Manolatos, D., Papathanakos, G., Vlachos, K., Tse, G., Korantzopoulos, P., Efremidis, M., Sideris, A., & Naka, K. K. (2019). The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study. Hippokratia, 23(3), 118-125.
Bazoukis, G, et al. "The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study." Hippokratia vol. 23,3 (2019): 118-125.
Bazoukis G, Saplaouras A, Letsas KP, Yeung C, Xydonas S, Karamichalakis N, Thomopoulos C, Manolatos D, Papathanakos G, Vlachos K, Tse G, Korantzopoulos P, Efremidis M, Sideris A, Naka KK. The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study. Hippokratia. 2019 Jul-Sep;23(3):118-125. PMID: 32581497; PMCID: PMC7307505.
Copy Download .nbib Format: NLM
Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Trachanas K, Sideris S, Arsenos P, Tsiachris D, Antoniou CK, Dilaveris P, Triantafyllou K, Xenogiannis I, Tsimos K, Efremidis M, Kanoupakis E, Flevari P, Vassilikos V, Sideris A, Korantzopoulos P, Tousoulis D, Tsioufis K, Gatzoulis K.
PMID: 34873786
Ann Noninvasive Electrocardiol. 2021 Dec 06;e12908. doi: 10.1111/anec.12908. Epub 2021 Dec 06.

BACKGROUND: In the PRESERVE-EF study, a two-step sudden cardiac death (SCD) risk stratification approach to detect post-myocardial infarction (MI) patients with left ventricle ejection fraction (LVEF) ≥40% at risk for major arrhythmic events (MAEs) was used. Seven noninvasive risk...

Cite
Trachanas K, Sideris S, Arsenos P, et al. Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study. Ann Noninvasive Electrocardiol. 2021;e12908doi: 10.1111/anec.12908.
Trachanas, K., Sideris, S., Arsenos, P., Tsiachris, D., Antoniou, C. K., Dilaveris, P., Triantafyllou, K., Xenogiannis, I., Tsimos, K., Efremidis, M., Kanoupakis, E., Flevari, P., Vassilikos, V., Sideris, A., Korantzopoulos, P., Tousoulis, D., Tsioufis, K., & Gatzoulis, K. (2021). Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, e12908. https://doi.org/10.1111/anec.12908
Trachanas, Konstantinos, et al. "Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study." Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc vol. (2021): e12908. doi: https://doi.org/10.1111/anec.12908
Trachanas K, Sideris S, Arsenos P, Tsiachris D, Antoniou CK, Dilaveris P, Triantafyllou K, Xenogiannis I, Tsimos K, Efremidis M, Kanoupakis E, Flevari P, Vassilikos V, Sideris A, Korantzopoulos P, Tousoulis D, Tsioufis K, Gatzoulis K. Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study. Ann Noninvasive Electrocardiol. 2021 Dec 06;e12908. doi: 10.1111/anec.12908. Epub 2021 Dec 06. PMID: 34873786.
Copy Download .nbib Format: NLM
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.

European journal of preventive cardiology

Zhang N, Wang Y, Tse G, Korantzopoulos P, Letsas KP, Zhang Q, Li G, Lip GYH, Liu T.
PMID: 34792124
Eur J Prev Cardiol. 2021 Nov 18; doi: 10.1093/eurjpc/zwab173. Epub 2021 Nov 18.

AIMS: To examine the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on cardiac remodelling in patients with type 2 diabetes mellitus (T2DM) and/or heart failure (HF), and to explore the subsets of patients who may have greater benefit from SGLT2i...

Cite
Zhang N, Wang Y, Tse G, et al. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. Eur J Prev Cardiol. 2021;doi: 10.1093/eurjpc/zwab173.
Zhang, N., Wang, Y., Tse, G., Korantzopoulos, P., Letsas, K. P., Zhang, Q., Li, G., Lip, G. Y. H., & Liu, T. (2021). Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. European journal of preventive cardiology, . https://doi.org/10.1093/eurjpc/zwab173
Zhang, Nan, et al. "Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis." European journal of preventive cardiology vol. (2021). doi: https://doi.org/10.1093/eurjpc/zwab173
Zhang N, Wang Y, Tse G, Korantzopoulos P, Letsas KP, Zhang Q, Li G, Lip GYH, Liu T. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. Eur J Prev Cardiol. 2021 Nov 18; doi: 10.1093/eurjpc/zwab173. Epub 2021 Nov 18. PMID: 34792124.
Copy Download .nbib Format: NLM
Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Sfairopoulos D, Zhang N, Wang Y, Chen Z, Letsas KP, Tse G, Li G, Lip GYH, Liu T, Korantzopoulos P.
PMID: 34333592
Europace. 2022 Jan 04;24(1):20-30. doi: 10.1093/europace/euab177.

AIMS : Sudden cardiac death (SCD) and ventricular arrhythmias (VAs) are important causes of mortality in patients with type 2 diabetes mellitus (T2DM), heart failure (HF), or chronic kidney disease (CKD). We evaluated the effect of sodium-glucose cotransporter-2 (SGLT2)...

Cite
Sfairopoulos D, Zhang N, Wang Y, et al. Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. Europace. 2022;24(1):20-30doi: 10.1093/europace/euab177.
Sfairopoulos, D., Zhang, N., Wang, Y., Chen, Z., Letsas, K. P., Tse, G., Li, G., Lip, G. Y. H., Liu, T., & Korantzopoulos, P. (2022). Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(1), 20-30. https://doi.org/10.1093/europace/euab177
Sfairopoulos, Dimitrios, et al. "Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials." Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology vol. 24,1 (2022): 20-30. doi: https://doi.org/10.1093/europace/euab177
Sfairopoulos D, Zhang N, Wang Y, Chen Z, Letsas KP, Tse G, Li G, Lip GYH, Liu T, Korantzopoulos P. Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. Europace. 2022 Jan 04;24(1):20-30. doi: 10.1093/europace/euab177. PMID: 34333592.
Copy Download .nbib Format: NLM
Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece.

American journal of cardiovascular disease

Bechlioulis A, Sfairopoulos D, Korantzopoulos P.
PMID: 34548948
Am J Cardiovasc Dis. 2021 Aug 15;11(4):489-493. eCollection 2021.

The coronavirus disease 2019 (COVID-19) pandemic seems to have a significant impact on cardiovascular-related hospital visits and admissions. The effect of the ongoing pandemic on the cardiac implantable electronic device (CIED) procedures is less well studied. We recorded and...

Cite
Bechlioulis A, Sfairopoulos D, Korantzopoulos P. Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece. Am J Cardiovasc Dis. 2021;11(4):489-493
Bechlioulis, A., Sfairopoulos, D., & Korantzopoulos, P. (2021). Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece. American journal of cardiovascular disease, 11(4), 489-493.
Bechlioulis, Aris, et al. "Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece." American journal of cardiovascular disease vol. 11,4 (2021): 489-493.
Bechlioulis A, Sfairopoulos D, Korantzopoulos P. Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece. Am J Cardiovasc Dis. 2021 Aug 15;11(4):489-493. eCollection 2021. PMID: 34548948; PMCID: PMC8449197.
Copy Download .nbib Format: NLM
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation.

Cardiology research and practice

Zhang N, Tse G, Dahal S, Yang Y, Gong M, Chan CZY, Liu E, Xu G, Letsas KP, Korantzopoulos P, Li G, Liu T.
PMID: 30622821
Cardiol Res Pract. 2018 Dec 04;2018:6047271. doi: 10.1155/2018/6047271. eCollection 2018.

BACKGROUND: Use of amiodarone (AMIO) in atrial fibrillation (AF) has significant side effects over prolonged periods. Wenxin Keli (WXKL), a Chinese herb extract, has been shown to be effective in atrial-selective inhibiting peak METHODS: A total of 41 patients...

Cite
Zhang N, Tse G, Dahal S, et al. Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation. Cardiol Res Pract. 2018;2018:6047271doi: 10.1155/2018/6047271.
Zhang, N., Tse, G., Dahal, S., Yang, Y., Gong, M., Chan, C. Z. Y., Liu, E., Xu, G., Letsas, K. P., Korantzopoulos, P., Li, G., & Liu, T. (2018). Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation. Cardiology research and practice, 20186047271. https://doi.org/10.1155/2018/6047271
Zhang, Nixiao, et al. "Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation." Cardiology research and practice vol. 2018 (2018): 6047271. doi: https://doi.org/10.1155/2018/6047271
Zhang N, Tse G, Dahal S, Yang Y, Gong M, Chan CZY, Liu E, Xu G, Letsas KP, Korantzopoulos P, Li G, Liu T. Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation. Cardiol Res Pract. 2018 Dec 04;2018:6047271. doi: 10.1155/2018/6047271. eCollection 2018. PMID: 30622821; PMCID: PMC6304890.
Copy Download .nbib Format: NLM
Serum potassium and heart failure: association, causation, and clinical implications.

Heart failure reviews

Sfairopoulos D, Arseniou A, Korantzopoulos P.
PMID: 33098029
Heart Fail Rev. 2021 May;26(3):479-486. doi: 10.1007/s10741-020-10039-9. Epub 2020 Oct 23.

Dyskalemia (hypo- and hyperkalemia) is a common clinical encounter in patients with heart failure (HF), linked to underlying pathophysiologic alterations, pharmacological treatments, and concomitant comorbidities. Both hypo- and hyperkalemia have been associated with a poor outcome in HF. However,...

Cite
Sfairopoulos D, Arseniou A, Korantzopoulos P. Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev. 2020;26(3):479-486doi: 10.1007/s10741-020-10039-9.
Sfairopoulos, D., Arseniou, A., & Korantzopoulos, P. (2021). Serum potassium and heart failure: association, causation, and clinical implications. Heart failure reviews, 26(3), 479-486. https://doi.org/10.1007/s10741-020-10039-9
Sfairopoulos, Dimitrios, et al. "Serum potassium and heart failure: association, causation, and clinical implications." Heart failure reviews vol. 26,3 (2021): 479-486. doi: https://doi.org/10.1007/s10741-020-10039-9
Sfairopoulos D, Arseniou A, Korantzopoulos P. Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev. 2021 May;26(3):479-486. doi: 10.1007/s10741-020-10039-9. Epub 2020 Oct 23. PMID: 33098029.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries